0000897069-24-000236.txt : 20240201
0000897069-24-000236.hdr.sgml : 20240201
20240201183203
ACCESSION NUMBER: 0000897069-24-000236
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240131
FILED AS OF DATE: 20240201
DATE AS OF CHANGE: 20240201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lin Patrick
CENTRAL INDEX KEY: 0001799363
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39531
FILM NUMBER: 24588275
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001533743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 451539785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
BUSINESS PHONE: 443-776-3133
MAIL ADDRESS:
STREET 1: 7380 COCA COLA DRIVE
STREET 2: SUITE 106
CITY: HANOVER
STATE: MD
ZIP: 21076
FORMER COMPANY:
FORMER CONFORMED NAME: Heatwurx, Inc.
DATE OF NAME CHANGE: 20111028
4
1
form4.xml
X0508
4
2024-01-31
0001533743
Processa Pharmaceuticals, Inc.
PCSA
0001799363
Lin Patrick
C/O PROCESSA PHARMACEUTICALS, INC.
7380 COCA COLA DRIVE, SUITE 106
HANOVER
MD
21076
true
Chief Business - Strategy Off
false
Common Stock
2024-01-31
4
P
0
2500
2.37
A
25978
D
Common Stock
2024-02-01
4
P
0
1500
2.4
A
27478
D
Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
2024-02-01